Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   HTML views PDF downloads Totals
25,537 Dovepress* 22,335+ 1,423 23,758
PubMed Central* 3,202 305 3,507
Totals 25,537 1,728 27,265
*Since 12 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
309 0 0 0 4 305

View citations on PubMed Central and Google Scholar